Dr. John Franklyn Riefler Iii, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 423 Colwell Ct, Ridgewood, NJ 07450 Phone: 201-652-3405 |
Deborah E Rudin, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 141 Dayton St, Ridgewood, NJ 07450 Phone: 201-447-6468 Fax: 201-447-3189 |
Dr. Simon John Tsiouris, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 947 Linwood Ave, Suite 2e, Ridgewood, NJ 07450 Phone: 201-447-6468 |
Dr. Tosca Elana Kinchelow, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 471 E Saddle River Rd, Ridgewood, NJ 07450 Phone: 201-925-2400 Fax: 201-612-1104 |
Neil Gaffin, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 947 Linwood Ave, Suite 2e, Ridgewood, NJ 07450 Phone: 201-447-6468 Fax: 201-447-3189 |
Carol Ann O'hagan Sotsky, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 947 Linwood Ave, Suite 2e, Ridgewood, NJ 07450 Phone: 201-447-6468 Fax: 201-447-3189 |
Lucy Cheng, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 947 Linwood Ave Ste 2e, Ridgewood, NJ 07450 Phone: 201-447-6468 Fax: 201-447-3189 |
News Archive
The Will Rogers Institute's annual prize for outstanding contributions to lung research has been awarded to Dr. Anthony Fauci. The $50,000 award was created to honor individuals for extraordinary work leading to advancements in treatment for lung diseases. He is the fourth recipient of the prestigious prize from the Will Rogers Institute.
Scientists have isolated cancer stem cells that lead to the growth of Wilms' tumours, a type of cancer typically found in the kidneys of young children. The researchers have used these cancer stem cells to test a new therapeutic approach that one day might be used to treat some of the more aggressive types of this disease.
Glycos Biotechnologies, Inc., an emerging biochemical company pioneering metabolic engineering and microbiology innovations for the production of sustainable biochemicals, today announced the company's international expansion into Malaysia.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.
› Verified 3 days ago